If you regularly deliver the same presentation, you may need to make small adjustments for different audiences or time ...
Thousands more patients with multiple sclerosis in England will soon be able to access Merck KGaA's take-at-home tablet Mavenclad, reducing their need for clinic visits. New guidance (PDF) from health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results